Information for healthcare providers on obtaining and using TPOXX (Tecovirimat) for treatment of monkeypox

i

Information for healthcare providers on obtaining and using TPOXX (Tecovirimat) for treatment of monkeypox

Supporting Files Public Domain

September 2, 2022
By National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.

File Language:

English

Details

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
Description:

Updated September 2, 2022

CDC, in partnership with FDA, has made it easier for healthcare providers to provide tecovirimat (TPOXX) treatment to patients with monkeypox under EA-IND. The streamlined process reduces the number of required forms and gives patients the option to see their doctor virtually.
Content Notes:

How to obtain TPOXX -- Protocol -- Required -- Optional -- Institutional Review Board (IRB) Approval
Subjects:

Antiviral Agents Drugs, Investigational Mpox (monkeypox) Poxviridae Infections/drug Therapy Smallpox/drug Therapy
Document Type:

Webpage
Name as Subject:

Tecovirimat ; Tecovirimat
Place as Subject:

United States
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:5a52eae40f074c38eaecb62728bdf1c6884fe908c8757cfeb100e53b6ee390dc
Download URL:

https://stacks.cdc.gov/view/cdc/120861/cdc_120861_DS1.pdf
File Type:

[PDF - 434.38 KB ]

obtaining-tecovirimat.html

html

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.